A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

Clinical trial NCT07401862 · RECRUITING

Trial details

NCT number: NCT07401862
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency

Start date: 2026-02-10
Primary completion: 2027-03-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.